MedPath

ciclopirox

Ciclopirox Gel 0.77%

Approved
Approval ID

3c22416e-4293-4ba5-a983-137cbc6022db

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 13, 2017

Manufacturers
FDA

Glenmark Pharmaceuticals Inc., USA

DUNS: 130597813

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

ciclopirox

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code68462-455
Application NumberANDA091595
Product Classification
M
Marketing Category
C73584
G
Generic Name
ciclopirox
Product Specifications
Route of AdministrationTOPICAL
Effective DateJanuary 13, 2017
FDA Product Classification

INGREDIENTS (7)

CICLOPIROXActive
Quantity: 7.7 mg in 1 g
Code: 19W019ZDRJ
Classification: ACTIB
ISOPROPYL ALCOHOLInactive
Code: ND2M416302
Classification: IACT
CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED)Inactive
Code: 4Q93RCW27E
Classification: IACT
MEDIUM-CHAIN TRIGLYCERIDESInactive
Code: C9H2L21V7U
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
SODIUM LAURYL SULFATEInactive
Code: 368GB5141J
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ciclopirox - FDA Drug Approval Details